Search Results - "Verdú, Míriam"

Breast cancer‐related lymphoedema: Risk factors and prediction model by Martínez‐Jaimez, Patricia, Armora Verdú, Miriam, Forero, Carlos G., Álvarez Salazar, Samantha, Fuster Linares, Pilar, Monforte‐Royo, Cristina, Masia, Jaume

“…Aims To identify the risk factors for lymphoedema following axillary lymph node dissection (ALND) in a European sample and to propose a lymphoedema prediction…”
Get full text

Validation of New International Prognostic Scores, Including Baseline Peripheral Blood Variables, in Patients with Diffuse Large B-Cell Lymphoma and HIV Infection Treated with R-CHOP and Combined Antiretroviral Therapy. Retrospective Study from Spanish Lymphoma Group Geltamo by Huguet, Maria, Morgades, Mireia, Lopez-Guillermo, Armando, Rivas-Delgado, Alfredo, Bastos-Oreiro, Mariana, Aldamiz-Echevarría, Teresa, Salar, Antonio, de la Cruz Vicente, Fátima, Alcoceba, Miguel, Ferrer Lores, Blanca, Jimenez-Ubieto, Ana, Gutierrez, Antonio, Infante, Maria Stefania, Huerga, Sofia, Abrisqueta, Pau, Cruz, David, Montalban, Carlos, Muntañola Prat, Ana, González de Villambrosia, Sonia, Verdú, Míriam, Sancho, Juan-Manuel, Ribera, Josep-Maria, Navarro, José-Tomás

“…Background Diffuse large B-cell lymphoma (DLBCL) is the most frequent subtype of HIV-associated lymphoma. Since the introduction of combined antiretroviral…”
Get full text

Sensitization to Api m 1, Api m 2, and Api m 4: association with safety of bee venom immunotherapy by Ruiz, Berta, MD, Serrano, Pilar, MD, PhD, Verdú, Miriam, MD, Moreno, Carmen, MD, PhD

Get full text

Sources of variability of the van Herick technique for anterior angle estimation by Gispets, Joan, Cardona, Genís, Verdú, Miriam, Tomàs, Núria

“…The purpose of the present study was to investigate two potential sources of variability of the traditional van Herick technique for temporal anterior chamber…”
Get full text

Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs by Broyles, Ana Dioun, Banerji, Aleena, Barmettler, Sara, Biggs, Catherine, Blumenthal, Kimberly, Brennan, Patrick, Breslow, Rebecca, Brockow, Knut, Buchheit, Kathleen, Cahill, Katherine, Cernadas, Josefina, Chiriac, Anca Mirela, Crestani, Elena, Demoly, Pascal, Dewachter, Pascale, Dilley, Meredith, Farmer, Jocelyn, Foer, Dinah, Fried, Ari, Garon, Sarah, Giannetti, Matthew, Hepner, David, Hong, David, Hsu, Joyce, Kothari, Parul, Kyin, Timothy, Lax, Timothy, Lee, Min Jung, Lee-Sarwar, Kathleen, Liu, Anne, Logsdon, Stephanie, Louisias, Margee, Macginnitie, Andrew, Maciag, Michelle, Minnicozzi, Samantha, Norton, Allison, Otani, Iris, Park, Miguel, Patil, Sarita, Phillips, Elizabeth, Picard, Matthieu, Platt, Craig, Rachid, Rima, Rodriguez, Tito, Romano, Antonino, Stone, Cosby, Torres, Maria Jose, Verdú, Miriam, Wang, Alberta, Wickner, Paige, Wolfson, Anna, Wong, Johnson, Yee, Christina, Zhou, Joseph, Castells, Mariana

Get full text

Rapid oral desensitization protocol to abiraterone acetate by Verdu, Miriam, Torres-Degayon, Virginia, Hassan-Bennis, Mohamed

Get full text

Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα by Castro-Villegas, Carmen, Pérez-Sánchez, Carlos, Escudero, Alejandro, Filipescu, Ileana, Verdu, Miriam, Ruiz-Limón, Patricia, Aguirre, Ma Angeles, Jiménez-Gomez, Yolanda, Font, Pilar, Rodriguez-Ariza, Antonio, Peinado, Juan Ramon, Collantes-Estévez, Eduardo, González-Conejero, Rocío, Martinez, Constantino, Barbarroja, Nuria, López-Pedrera, Chary

“…The advent of anti-tumor necrosis factor alpha (anti-TNFα) drugs has considerably improved medical management in rheumatoid arthritis (RA) patients, although…”
Get full text

Lymphomagenic Roles of MYC, E2F and Mir-150-5p in Plasmablastic Lymphoma: Therapeutic and Prognostic Implications by Verdú Bou, Miriam, Baptista, Maria Joao, Mendez Lopez, Aleix, Tapia, Gustavo, Ribeiro, Marcelo Lima, Roué, Gaël, Mate, Jose Luis, Abrisqueta, Pau, Bastos-Oreiro, Mariana, Alcoceba, Miguel, González Barca, Eva, Climent, Fina, Salar, Antonio, Sancho, Juan-Manuel, Frontzek, Fabian, Staiger, Annette M., Ott, German, Castro De Moura, Manuel, Lenz, Georg, Navarro, Jose Tomas

Get full text

Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNF[alpha] by Castro-Villegas, Carmen, Pñrez-Sánchez, Carlos, Escudero, Alejandro, Filipescu, Ileana, Verdu, Miriam, Ruiz-Limón, Patricia, Aguirre, Ma Angeles, Jimñnez-Gomez, Yolanda, Font, Pilar, Rodriguez-Ariza, Antonio, Peinado, Juan Ramon, Collantes-Estñvez, Eduardo, González-Conejero, Rocío, Ma, Barbarroja, Nuria, López-Pedrera, Chary

“…Introduction The advent of anti-tumor necrosis factor alpha (anti-TNF[alpha]) drugs has considerably improved medical management in rheumatoid arthritis (RA)…”
Get full text

Clinical and Therapeutic Implications of Epstein-Barr Virus in HIV-Related Lymphomas by Verdu-Bou, Miriam, Tapia, Gustavo, Hernandez-Rodriguez, Agueda, Navarro, Jose-Tomas

“…The incidence of lymphomas is increased in people living with HIV (PLWH). Aggressive B-cell non-Hodgkin lymphomas (NHLs) are the most common and are considered…”
Get full text